Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Karine Bouhier Leporrier"'
Autor:
Flavie Thomas, Benjamin Menahem, Gil Lebreton, Karine Bouhier-Leporrier, Olivier Dejardin, Arnaud Alves
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
ObjectivesThis study aimed: (i) to assess the cumulative incidence of permanent stoma (PS) after sphincter-preserving surgery (SPS) for rectal cancer (RC): (ii) to analyze associated risk factors for primary and secondary PS; and (iii) to compare the
Externí odkaz:
https://doaj.org/article/3539d15c1df44598ab4de703a5712f5a
Autor:
Audrey Fohlen, Remi Beaudouin, Arnaud Alvès, Karine Bouhier-Leporrier, Christophe Pasik, Jean-Pierre Pelage
Publikováno v:
Cancers, Vol 15, Iss 16, p 4021 (2023)
Background: The purpose of this study was to evaluate the clinical, biological and radiological responses to, and tolerability of, conventional transarterial chemoembolization (cTACE) using streptozocin for unresectable neuroendocrine liver metastase
Externí odkaz:
https://doaj.org/article/4c9377635e9a40deb3b24a70324b476b
Autor:
Quentin Rollet, Véronique Bouvier, Grégoire Moutel, Ludivine Launay, Anne-Laure Bignon, Karine Bouhier-Leporrier, Guy Launoy, Astrid Lièvre
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Multidisciplinary team meetings (MDTMs) are part of the standard cancer care process in many European countries. In France, they are a mandatory condition in the authorization system for cancer care administration, with the goal t
Externí odkaz:
https://doaj.org/article/81be88e241de40899c3201f1765afad3
Autor:
David Sefrioui, Ludivine Beaussire, André Gillibert, France Blanchard, Emmanuel Toure, Céline Bazille, Anne Perdrix, Frédéric Ziegler, Alice Gangloff, Mélanie Hassine, Caroline Elie, Anne-Laure Bignon, Aurélie Parzy, Philippe Gomez, Caroline Thill, Florian Clatot, Jean-Christophe Sabourin, Thierry Frebourg, Jacques Benichou, Karine Bouhier-Leporrier, Marie-Pierre Gallais, Nasrin Sarafan-Vasseur, Pierre Michel, Frédéric Di Fiore
Publikováno v:
British Journal of Cancer
British Journal of Cancer, Cancer Research UK, 2021, ⟨10.1038/s41416-021-01431-9⟩
Br J Cancer
British Journal of Cancer, Cancer Research UK, 2021, ⟨10.1038/s41416-021-01431-9⟩
Br J Cancer
BACKGROUND: We previously reported that CEA kinetics are a marker of progressive disease (PD) in metastatic colorectal cancer (mCRC). This study was specifically designed to confirm CEA kinetics for predicting PD and to evaluate CA19-9, cell-free DNA
Autor:
Hubert Benoist, Amandine Busson, Audrey Faveyrial, Karine Bouhier-Leporrier, Fabienne Divanon, Cécile Breuil, Sophie Roger-Leenaert, Agnès Palix, Pascal Odou, Nicolas Simon, Guillaume Saint-Lorant
Publikováno v:
Journal of Oncology Pharmacy Practice
Journal of Oncology Pharmacy Practice, 2022, Journal of Oncology Pharmacy Practice, pp.10781552221103803. ⟨10.1177/10781552221103803⟩
Journal of Oncology Pharmacy Practice, 2022, Journal of Oncology Pharmacy Practice, pp.10781552221103803. ⟨10.1177/10781552221103803⟩
Background Antineoplastic drug exposure is a major problem in regard to caregivers’ health. The aim of the present study was to assess the perception, knowledge, and handling practices of all occupation level categories of two oncology day hospital
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f821b5a257de186579f921f52b515f97
https://hal.univ-lille.fr/hal-04160075
https://hal.univ-lille.fr/hal-04160075
Autor:
David Malka, Benoît Dupont, Alain Gratet, Pamela Biondiani, Marion Chauvenet, Dany Gargot, Pierre-Emmanuel Henneresse, Hortense Laharie, Johann Dreanic, Valérie Lebrun Lyat, Catherine Brezault-Bonnet, Morgan Andre, Géraldine Perkins, Philippe Houyau, Yves Rinaldi, Etienne Suc, Dominique Besson, Valérie Boige, Cécile Julien, Julien Taieb, Simon Pernot, Benoît Avisse, Pauline Regnault, Ahmed Bedjaoui, Marie-Pierre Galais, Côme Lepage, Céline Lepère, Mme E. Barbier, Antoine Holllebecque, Anne Escande, Julie Vincent, Sandrine Lavau denes, Marie-Claude Gouttebel, Leila Bengrine Lefevre, Anne Thirot Bidault, Anne-Laure Pointet, Julie Gigout, Faiza Khemissa Akouz, Louis-Marie Dourthe, Frederick Moryoussef, Maxime Lesouef, Vincent Bourgeois, François Ghiringhelli, Patrick Texereau, Samy Louafi, Gildas Phelip, Yann Berge, Jean-François Codoul, Jérôme Chamois, Eric Terrebonne, Karine Bouhier Leporrier, Bidaut Wahiba, X. Artignan, Pr Pierre Michel, Iulia Pripon, David Sefrioui, Pierre-Luc Etienne, Romain Coriat, Aurélie Parzy, Mustapha Atlassi, Aziz Zaanan, Jean-Baptiste Bachet, Philippe Dominici, Jean Martin, Mathilde Martinez, Dominique Genet, Raymond Despax, Karine Le Malicot, Laurent Miglianico, Salvatore Caruso, Bruno Valenza, Nicolas Barriere, Oana Zveltlana Cojocarasu
Publikováno v:
European Journal of Cancer. 136:25-34
Background Chemotherapy is effective in metastatic pancreatic adenocarcinoma (mPA), but new approaches are still needed to improve patients' survival and quality of life. We have previously published good efficacy and tolerability results on a sequen
Autor:
Emeric Boisteau, Alexandra Lespagnol, Marie De Tayrac, Sébastien Corre, Anthony Perrot, Nathalie Rioux-Leclercq, Séverine Martin-Lannerée, Pascal Artru, Philippe Chalabreysse, Pierre-Guillaume Poureau, Laurent Doucet, Dahna Coupez, Jaafar Bennouna, Céline Bossard, Romain Coriat, Frédéric Beuvon, Lucile Bauguion, François Leclair, Romain Chautard, Thierry Lecomte, Serge Guyetant, Romain Desgrippes, Denis Grasset, Hélène Lhostis, Karine Bouhier-Leporrier, Frédéric Bibeau, Julien Edeline, Marie-Dominique Galibert, Astrid Lièvre
Publikováno v:
Clinics and Research in Hepatology and Gastroenterology
Clinics and Research in Hepatology and Gastroenterology, Elsevier, 2022, 46 (5), 11 p. ⟨10.1016/j.clinre.2022.101888⟩
Clinics and Research in Hepatology and Gastroenterology, 2022, 46 (5), 11 p. ⟨10.1016/j.clinre.2022.101888⟩
Clinics and Research in Hepatology and Gastroenterology, Elsevier, 2022, 46 (5), 11 p. ⟨10.1016/j.clinre.2022.101888⟩
Clinics and Research in Hepatology and Gastroenterology, 2022, 46 (5), 11 p. ⟨10.1016/j.clinre.2022.101888⟩
International audience; BACKGROUND: Low miR-31-3p expression was identified as predictive of anti-EGFR efficacy in RAS-wt mCRC. Primary tumor side was also proposed as a predictive factor of anti-EGFR benefit. This retrospective multicentric study ev
Autor:
Ludovic Rosenfeld, Virginie Berger, Erick Gamelin, Karine Bouhier-Leporrier, Claire Stampfli, Isabelle Baumgaertner, Thierry Lecompte, Mehdi Kaassis, Eric Francois, Christophe Borg, Alain Morel, Celia Roemer-Becuwe, Veronique Guerin-Meyer, Roger Faroux, Michèle Boisdron-Celle, Oana Cojocarasu, Jean Philippe Metges, Olivier Capitain, Marie Pierre Galais, Jaafar Bennouna
Publikováno v:
Seminars in Oncology. 44:13-23
5-Fluorouracil (5-FU)–based treatments can lead to early-onset severe (4%–5%) even fatal (0.3%) toxicities in patients with dihydropyrimidine dehydrogenase (DPD) deficiency. This multicenter prospective cohort study aimed to assess the clinical b
Autor:
Audrey Mailliez, Bénédicte Clarisse, Audrey Emmanuelle Dugué, Delphine Mariotte, Sylvie Zanetta, Annie Peytier, Cristian Moldovan, Stéphanie Dakpé, Pascal Do, Bruno Chauffert, Jean-Marie Reimund, Roland Schott, M.P. Galais, Emmanuel Babin, Benoît Dupont, Radj Gervais, Frédéric Di Fiore, Brigitte Le Mauff, Jean-Michel Grellard, Carmen Florescu, Karine Bouhier-Leporrier
Publikováno v:
British Journal of Clinical Pharmacology. 83:623-631
Aim Cetuximab is an anti-epidermal growth factor receptor antibody used for the treatment of metastatic colorectal cancer and head and neck cancer. Hypersensitivity reactions (HSRs) are associated with cetuximab use. The aim of the study was to evalu
Autor:
Anne-Laure Bignon, A. Parzy, Alice Gangloff, Karine Bouhier-Leporrier, Sabrina Sidali, Frédéric Di Fiore, David Sefrioui, M. Hassine, Marie-Pierre Galais, Pierre Michel, Lucie Laurent
Publikováno v:
HPB
HPB, Wiley, 2019, 21, pp.582-588. ⟨10.1016/j.hpb.2018.09.006⟩
HPB, Wiley, 2019, 21, pp.582-588. ⟨10.1016/j.hpb.2018.09.006⟩
Background Although carbohydrate antigen 19.9 (CA19.9) is widely used in pancreatic adenocarcinoma (PA), no consensual cut-off value of CA19.9 decrease has been established for treatment monitoring. Methods This was a retrospective study including pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d611f2dafbb8f8ebb3d0a1249a26e88
https://hal.archives-ouvertes.fr/hal-03486435
https://hal.archives-ouvertes.fr/hal-03486435